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ABSTRACT 
 
Purpose: The aim of the study was to quantify the total coronary atherosclerotic burden in patients with 
suspected coronary artery disease (CAD) defined by coronary computed tomography adapted Leaman score 
(CT-LeSc) and to estimate its cut-off level for high coronary atherosclerotic burden.  
Methods: We enrolled 434 consecutive patients referred to coronary computed tomography angiography, of 
which 261 patients fulfilled the study inclusion criteria. Demographic and clinical characteristics, as well as 
CAD risk factors were obtained. CAD pre-test probabilities were estimated by the Diamond-Forrester model and 
Morise score. The coronary atherosclerotic burden was estimated using CT-LeSc. As a cut-off for a high 
coronary atherosclerotic burden, we used 3rd tercile (Tc3) (CT-LeSc≥5.52). We evaluated the association of 
clinical characteristics and risk factors with Tc3 in univariate and multivariate analysis.  
Results: There were 60.9% males and 39.1% females, 81% of patients had above-normal weight, 68.2% 
hypertension, 54.0% dyslipidemia, 15.3% diabetes mellitus, 12.3% positive smoking history and 11.9% had a 
family history of CAD. According to the Diamond-Forrester model and Morise score the majority of patients had 
intermediate risk, 59.7% and 52.8%, followed by the high-risk group, 36.0% and 34.4%, respectively. Age, 
dyslipidaemia, hypertension and pre-test risk scores in the univariate analysis significantly predicted Tc3. In the 
multivariate analysis, male sex (p=0.004), dyslipidaemia (p=0.002) and coronary calcium score (<0.001) were 
identified as predictors of Tc3.  
Conclusion: CT-LeSc quantified the total coronary atherosclerotic burden and showed an association of risk 
factors and pre-test probabilities with Tc3.  
 
Keywords: coronary CT angiography, CT-adapted Leaman score, coronary atherosclerotic burden, pre-test 
probability  
 
 
 
INTRODUCTION 
 
Cardiovascular diseases (CVD) are the major cause of death in Europe. Despite the decrease in mortality 
observed during the last decade, coronary artery disease (CAD) is the leading cause of death [1]. In Croatia, 
modest decline in mortality may be attributed to combination of primary prevention and easy access to invasive 
coronary angiography (ICA), as well as subsequent revascularisation in patients with obstructive CAD. Unlike 
ICA that predominately provides insight into the coronary artery lumen, coronary computed tomography 
angiography (cCTA) as a noninvasive imaging method allows comprehensive and multifaceted assessment of the 
coronary artery lumen and vessel walls including atherosclerotic plaques, with high diagnostic performance for 
the detection and exclusion of CAD [2]. Therefore, cCTA is increasingly being used as a method for accurate 
cardiovascular risk stratification by the total coronary artery plaque burden based on specific scores. Some of 
these scores have already been developed and validated for cCTA, such as segment involvement score (SIS) and 
segment stenosis score (SSS) [3]. The original Leaman score was developed almost four decades ago for ICA to 
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quantify the burden of obstructive CAD [4]. It served as a foundation for the recent development and validation 
of the comprehensive measure of the total coronary atherosclerotic burden – the cCTA-adapted Leaman score 
(CT-LeSc) [5]. Despite the existence of the aforementioned radiological scores aimed at the precise assessment 
of coronary atherosclerotic burden, commonly used pre-test probability (PTP) composite scores (based on 
atherosclerotic risk factors) are still considered the mainstay of risk assessment by the majority of cardiologists. 
However, none of the PTP scores have been validated for use in association with cCTA as the sole diagnostic 
test. The morphologic heterogeneity within the cardiovascular continuum maintains the need for precise 
quantification and accurate risk stratification of CAD patients.  
The major objective of the study is to quantify the total coronary atherosclerotic burden in patients with 
suspected CAD defined by CT-LeSc and to estimate its cut-off level for high coronary atherosclerotic burden. 
The second objective is to assess the association of cardiovascular risk factors, PTP scores and coronary artery 
calcium score (CACS) with high coronary atherosclerotic burden.  
 
 
MATERIALS AND METHODS 
 
Study population  
This single center cross-sectional study was conducted using data from the clinical database of Polyclinic Sunce, 
Zagreb, Croatia in 2017. From January to June 2008 we scanned 434 consecutive patients ≥18 years of age 
referred to cCTA for a variety of clinical indications: suspected or previously undiagnosed CAD in patients with 
abnormal or inconclusive stress test results, chest pain symptoms, presence of multiple CAD risk factors, atrial 
fibrillation and other arrhythmias, evaluation prior to coronary artery bypass graft surgery or valve replacement, 
follow-up of previous coronary artery bypass graft surgery and implanted coronary stents, evaluation of the great 
cardiac vessels, cerebrovascular and peripheral artery disease, as well as chronic renal disease. Patients were 
excluded if they had: (1) history of previous myocardial infarction with or without coronary revascularization 
(coronary bypass and/or percutaneous coronary intervention (PCI)) or previous PCI with coronary stent 
implantation (n=76), (2) chronic renal disease (glomerular filtration rate < 15 mL/min/1.73m2 and dialysis)  
(n=8), (3) cCTA performed as a part of the evaluation of great cardiac vessels or valvular disease (n=46), (4) 
atrial fibrillation and other arrhythmias (n=25), and (5) previously known cerebrovascular and/or peripheral 
artery disease (n=18). The total number of excluded patients was 173. Finally, 261 patients with the following 
clinical presentations were evaluated: (1) stable chest pain with one or more CAD risk factors, (2) positive, 
inconclusive or discordant stress test, and (3) absent chest pain but presence of multiple CAD risk factors. 
Figure1 describes patient selection and study design. 
The study design was approved by the institutional ethics committee. 
 
Acquisition of clinical data and calculation of pre-test probability for CAD 
Prior to cCTA, the patients’ medical documentation was reviewed and a structured interview was conducted by 
two cardiologists. They collected clinical and demographic data, assessed the cardiac risk profile (cardiovascular 
risk factors), evaluated symptoms associated with CAD and performed a physical examination. Diabetes mellitus 
was defined as fasting glucose ≥7 mmol/L or the use of insulin or oral hypoglycaemic agents. Dyslipidemia was 
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defined as a total cholesterol level ≥5 mmol/l or treatment with lipid-lowering medications [6]. Systemic arterial 
hypertension was defined as systolic blood pressure ≥140 mmHg regardless of antihypertensive therapy [7]. 
Obesity was defined as body mass index ≥30 kg/m2 [8]. Current smokers and patients that smoked within a year 
prior to observation were considered to have a positive smoking history [5]. Family history of CAD was 
considered positive if there was a history of myocardial infarction, coronary bypass or angioplasty, or sudden 
death in first-degree relatives at the age <55 years for males and <65 years for females [5]. PTP for CAD was 
assessed using the Morise and Diamond-Forrester (DF) scores. The Morise score includes age, gender, estrogen 
status, cardiovascular risk factors and chest pain symptoms. According to the Morise score, patients were 
divided into low (0-8), intermediate (9-15), and high (≥16) risk groups (9). The DF score takes into account age, 
sex, and type of chest pain (typical, atypical or non-anginal) and classifies patients into low, intermediate and 
high-risk categories [10]. 
 
Scan protocol 
All patients were scanned on a 64-slice dual-source CT scanner (Somatom Definition, Siemens Medical 
Solutions, Forchheim, Germany). Scanning parameters were as follows: detector collimation 2×2×0.6 mm3, slice 
collimation 2×64 0.6 mm3 by means of a z-flying focal spot, gantry rotation time 330 ms, and pitch of 0.2-0.5 
depending the heart rate [11, 12]. Images were acquired in the mid-diastole and individually adjusted position of 
the reconstruction window, and, if necessary, additionally reconstructed in the end-systole. For the purpose of 
analysis, we used the data-set of axial slices, multiplanar reformations, and thin-slab maximum intensity 
projections, such as 5-mm thickness and 1-mm increments. Patients with a heart rate ≥60 beats/min were 
administered intravenously up to four doses of 5 mg metoprolol to lower the heart rate. Patients with a systolic 
blood pressure ≥100 mmHg received nitroglycerin 0.8 mg sublingually for coronary vasodilatation.  
Coronary artery calcium scoring (CACS) was performed in all study patients, according to a previously 
described protocol, and the Agatston score was used to quantify total coronary calcium per patient [13, 14]. 
Contrast timing was tested by an initial bolus-timing scan using 20 mL of contrast (Iopamiro 370, Bracco S.p.a, 
Milan, Italy), iodine content 37 mg/mL, followed by a 50 mL saline chaser. The contrast-enhanced scan was 
obtained using 80-140 mL of contrast individually adapted to the selected table feed and scan range at a rate of 
4-6 mL/s followed by a 50mL saline chaser.  
 
Radiation dose 
The effective radiation dose of the CACS and cCTA scan was estimated by the product of the total dose length 
product from the dose report of the CT scanner and a European Commission conversion factor for the chest 
0.014 mSv·mGy-1·cm-1 (effective dose (mSv) = total dose length product (mGycm) x 0.014 mSv·mGy-1·cm-1) 
[15].  
 
Image analysis 
The images were analysed by two trained radiologists (L.P. and P.M.) experienced in cardiac CT and cCTA 
analysis. In case of disagreement, a joint reading was performed, and a consensus decision was reached. 
Coronary atherosclerotic lesions were quantified for stenosis by visual estimation. The proportion of coronary 
artery lumen tree was segmented according to the modified American Heart Association (AHA) classification 
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[16]. Each segment with a diameter ≥1.5 mm was evaluated visually for the level of luminal narrowing, and then 
categorized semi-quantitatively into four groups: <25%, 25-49%, 50-74%, and ≥75%. Obstructive coronary 
artery disease was defined as stenosis of 50% or more of the diameter of the left main coronary artery, and 
stenosis of 70% or more of the diameter of a major epicardial or branch vessel that was >2.0 mm in diameter. 
The luminal diameter of the normal appearing vessel site directly proximal to the plaque served as a reference 
for comparison.  
 
Classification of patients according to quantitative scores based on cCTA 
Using the presence and extent of CAD, each patient was categorized as having no CAD or having non-
obstructive (<50% stenosis) and obstructive disease (≥50% stenosis) [17]. 
CACS was categorized by employing the previously described scoring system as follows: no calcification (0), 
low (1-100), moderate (101-400) and severe (>400). 
The total coronary atherosclerotic burden was quantified by CT-LeSc, which employs three sets of weighting 
(multiplication) factors using an 18-segment coronary model: (1) localization of plaques, accounting for 
dominance [left main (right dominance×5, left dominance×6), LAD (proximal LAD × 3.5, mid LAD × 2.5, and 
distal LAD×1) etc.]; (2) type of plaque, with a multiplication factor of 1 for calcified plaques and of 1.5 for non-
calcified and mixed plaques; and (3) degree of stenosis, with a multiplication factor of 0.615 for non-obstructive 
and <50% stenosis, and a multiplication factor of 1 for ≥50% lesions [5]. The CT-LeSc on the individual level 
was calculated as the sum of the partial CT-LeSc of all evaluable coronary segments. Since there were no 
previously validated cut-offs for the CT-LeSc, the obtained scores were divided into terciles. The upper tercile 
(Tc3) of the CT-LeSc distribution within the total patient sample was considered equivalent to high coronary 
atherosclerotic burden. 
 
Statistical analysis including the prediction of high coronary atherosclerotic burden 
Results were presented numerically and graphically. Continuous variables were expressed as means and 95% 
confidence intervals or medians. Categorical variables were expressed as frequencies with percentages. The 
Kolmogorov-Smirnov test was used to assess normality of distribution. The independent samples t-test was 
employed to compare means of continuous variables, and the Pearson χ2 test was used to evaluate differences in 
frequencies of categorical variables. Differences were regarded significant when p<0.05 (2-tailed).  
In the univariate analysis, single atherosclerotic risk factors, PTP scores and CACS were compared between 
patients with and without high coronary atherosclerotic burden (defined as mentioned above). The predictive role 
of the same variables was assessed in a multivariate logistic regression model, where high coronary 
atherosclerotic burden was used as the outcome variable. All analyses were performed with statistical package 
IBM SPSS Statistics version 23, licence owned by the Croatian Institute of Public Health. 
 
 
RESULTS 
 
In our study population of 261 patients, there were 159 (60.9%) males and 102 (39.1%) females. CAD risk 
factors were highly prevalent (Table 1).  
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Chest pain was detected in 211 patients, 88 (41.7%) had typical angina, 103 (48.6%) had atypical angina, while 
21 (9.9%) exhibited non-anginal chest pain. The remaining 50 patients reported no chest pain. 
Both PTP scores (DF and Morise) classified the majority of symptomatic patients into the intermediate risk 
group as presented in Figure 2. 
More than two thirds of patients were diagnosed with CAD (188 patients, 72%). Within this group, non-
obstructive CAD was more frequently observed than its obstructive counterpart (57.4% vs. 42.6%). 
The median CACS was 16.7 among CAD patients: 192.7 in the obstructive in contrast to only 2.5 in the non-
obstructive CAD subgroup. The median CACS was 61.9 and 50.3 in high-risk patients according to the Morise 
and DF score, respectively. Patients with no chest symptoms had a median CACS of 33.3. CACS categories in 
relation to CAD subgroups are presented in Figure 3.  
The median CT-LeSc in the study population (n=261) was 3.22. In patients with CAD (n=188) the median CT-
LeSc was 5.22: 3.22 in the non-obstructive and 7.4 in the obstructive CAD subgroup. In the total study sample 
(n=261), the cut-off between the central and highest tercile (Tc) was 5.52. Patients with a CT-LeSc above this 
cut-off (i.e. categorized into the highest tercile, Tc3) were considered to have a high coronary atherosclerotic 
burden. The distribution of the CT-LeSc terciles in the study sample was as follows: Tc1 (0 - 0.92), Tc2 (0.93 - 
5.51) and Tc3 (5.52 - 16.25). 
Among 188 patients with CAD, 88 (46.8%) had a high coronary atherosclerotic burden (Tc3). The majority of 
patients with non-obstructive disease (n=87, 80.5%) were allocated into the lower two terciles, while the 
remaining 19.5% (n=21) had a high total coronary atherosclerotic burden (CT-LeSc≥5.52). Conversely, the 
majority of obstructive CAD patients, 84.9% (n=67), were allocated into the highest CT-LeSc tercile. The 
median CT-LeSc was slightly higher in males compared to females (3.63 vs. 2.61, respectively).  
The univariate analysis revealed a positive association between higher age, dyslipidaemia, and hypertension with 
a high coronary atherosclerotic burden. (Table 2). 
The same set of variables (with the exception of PTP scores) was included in the multivariate model to identify 
the predictors of high coronary atherosclerotic burden (Table 3). PTP scores were not included in the 
multivariate model to avoid collinearity, since they are composite measures of single variables already included 
in the model. Mean effective radiation dose was 21.9 mSv (95% confidence interval 20.9 - 22.8). 
 
 
DISCUSSION 
 
A high prevalence of CAD risk factors was observed in our study population, including dyslipidemia (54%), 
hypertension (68.2%), and above normal weight (81%). The smoking prevalence was rather low (12.3%) 
compared to the study by Vrazic et al. with 42.6% smokers among CAD patients [18]. Although cigarette 
smoking is a major risk factor for CAD, its lacking association with high coronary atherosclerotic burden can   
probably be ascribed to low prevalence in our study population. Overall, these results are suggestive of a high 
prevalence of CAD risk factors in the general population.  
The cardiac risk assessment based on traditional risk factors represents the first step in predicting cardiovascular 
outcomes, but the ideal formula for integration of risk factors and their permutation leading to the score with 
accurate pre-test probability is still unknown. Some of the risk scores are used more frequently based on their 
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verified clinical benefit, easy implementation, low cost and easy access, but there is widespread use of different 
scores with their advantages, such as good definition of broad categories, but also downsides, such as poor 
identification of the intermediate risk population [10, 19, 20]. In our study we used the Diamond Forrester and 
Morise pre-test probability models which are firmly established in clinical practice and research. The majority of 
participants, according to the Morise score, were in the intermediate risk group (52.8%), followed by high 
(34.4%) and low (12.6%) risk groups. The distribution was similar with the Diamond Forrester pre-test 
probability model. The highest proportion of participants was categorised into the intermediate risk group  
(59.9%), followed by high-risk group (35.8%). 
Despite the fact that these pre-test scores overestimate the CAD prevalence, the majority of coronary artery 
events occur on a substrate of moderate to severe atherosclerosis [21-23]. Most of the standard pre-test risk 
scores fail to predict major cardiac events in 75% of patients, thus underlining the need for a more accurate 
stratification tool [24]. Compared with conventional risk assessment methods, cCTA together with CACS has 
the ability to reclassify the patients at risk for CAD [25]. Prior to the introduction of more advanced coronary 
arterial plaque assessment methods, CACS had been an indirect determinant of the overall coronary plaque 
burden. It has been associated with an increased risk of myocardial infarction and death, as well as increased 
proximal stenosis burden [26]. However, measurement of the CACS as the only method of atherosclerotic 
burden assessment has limitation, because it does not anticipate the portion of the burden ascribable to low 
calcium density plaques. This diagnostic limitation was demonstrated in studies reporting coronary artery events 
and coronary obstructive disease in patients with a calcium score of zero [27]. 
In our study, the median CACS was 16.7 in the CAD group, 192.7 in the obstructive and 2.5 in the non-
obstructive CAD group. Almost one quarter of patients in the low CACS group had obstructive CAD. 
Conversely, more than one fifth in the severe CACS group had non-obstructive CAD. Findings of a calcium 
score being a predictor of high coronary atherosclerotic burden are in line with the results of a pre-coronary-CT 
era large histological study confirming a high correlation between the overall coronary calcium and 
atherosclerotic plaque burden [28]. Increased coronary calcium and atherosclerotic plaque burden have been 
associated with an increased risk of mortality and coronary events on the patient level, however it is still unclear 
whether higher or lower calcium density more accurately correlates with the (increased) risk of coronary events 
on the plaque level [28-30]. This is due to the still unclear relationship between plaque calcification and its 
vulnerability or propensity of plaque towards rupture. Coronary calcium might even play a protective role 
against plaque vulnerability, so it can be postulated that a pattern of high atherosclerotic burden in concert with a 
low calcium score (high burden/low calcium pattern) may be associated with a higher risk of coronary events 
compared to the high burden/high calcium pattern.  
CCTA is a suitable method for more accurate cardiovascular risk stratification by the total coronary artery 
plaque burden based on specific scores. Some scores have been developed and validated for cCTA, such as SIS 
and SSS, but concerning their ability to correctly reclassify the patients at risk, they have limitations compared 
with CT-LeSc [3, 31]. CT-LeSc uses plaque localization, degree of stenosis, plaque composition and takes into 
account the anatomical blood supply dominance of the coronary tree, enabling standardized assessment of the 
total coronary atherosclerotic burden. Given the lack of previously validated values, the 3rd tercile has been used 
as a cut-off for high coronary atherosclerotic burden (Tc3≥5.52). CT-LeSc has some limitations since it does not 
take into account the features of high-risk plaque, such as positive remodelling, low attenuation plaque and 
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napkin-ring sign, which influence the outcomes [32]. CT-LeSc improved the prognostic stratification and is an 
independent long-term predictor of hard cardiac events [33].  
Our study revealed that almost one fifth of the patients with non-obstructive CAD had CT-LeSc in the highest 
tercile and, conversely, 15.1% with obstructive CAD had CT-LeSc in lower terciles. These findings are in line 
with the previous study from de Araujo Gonçalves et al. [5], and emphasise the variety of CAD and the need for 
exact quantification in order to accurately stratify patients with increased risk for future cardiac events. 
Quantification of coronary atherosclerotic burden with non-invasive coronary imaging seems to provide a better 
insight into the complex morphology of coronary atherosclerosis compared to conventional coronary 
classification. While the ICA-based classification of coronary artery obstruction relies on the percentage of 
luminal stenosis and considers significant obstruction of coronary arteries higher of 50%, cCTA can precisely 
detect high-risk plaque features, such as positive remodelling, necrotic core, napkin ring sign and spotty 
calcification. The requirement to substitute conventional coronary angiography with CT in low and intermediate 
PTP patients with suspected CAD becomes increasingly visible in clinical cardiology practice [33-35]. 
 
Limitations 
Despite the fact that data analysis was performed in 2017, the extent and quality of data obtained in 2008 (stored 
in the clinical database), as well as stored original CT records, allowed us to calculate the required pre-test scores 
as well as the CT-LeSc. The time of observation was limited to the study period in 2008 because during that time 
the Polyclinic Sunce had a contract with the Croatian Health Insurance Fund (CHIF), a mandatory national 
health insurance covering the expenses of all diagnostic procedures. Complete coverage of costs by the national 
health insurance enabled us to recruit patients from the general population. The study could not have been 
extended thereafter since the contract with CHIF was not renewed. Nevertheless, studies with the larger sample 
size might more precisely quantify the association of classical cardiovascular risk factors and coronary 
atherosclerotic burden.   
 
Conclusion 
CT-LeSc enabled the quantification of the total coronary atherosclerotic burden and precise cut-off value for 
high coronary atherosclerotic burden among patients with suspected CAD, including obstructive and non-
obstructive subgroups. CT-LeSc revealed that non-obstructive plaques can be associated with a high coronary 
atherosclerotic burden; conversely, a single obstructive plaque can be quantified as a low atherosclerotic burden. 
These results accentuate the heterogeneity of the CAD and a more careful approach especially to non-obstructive 
CAD.  
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Table 1 Baseline demographic and clinical characteristics 
 
Variable Value 
Mean age (years) 
Males/Females 
58.9, CI 57.6-60.3 
62.3/56.7 
Males/Females 159 (60.9%)/102 (39.1%) 
Hypertension (mmHg) 178 (68.2%) 
Diabetes mellitus 40 (15.3%) 
Smoking 32 (12.3%) 
Body mass index kg/m2 28.6, CI 28.1-29.1 
<25 (normal weight) 49 (19%) 
25-30 (overweight) 126 (48.8%)  
>30 (obese) 83 (32.2%) 
Dyslipidemia 141 (54%) 
Family history of CAD+ 31 (11.9%) 
All data expressed as no., (%) or mean with confidence interval (CI)  
+coronary artery disease  
 
 
Table 2 Univariate predictors of high coronary atherosclerotic burden (CT LeSc T3) 
 
Variable Value CT LeSc T1+T2 CT LeSc T3 p-value 
Age  56.8 63.1 p=0.026* 
Male 
Female 
 98 (56.6%) 
75 (43.4%) 
61 (69.3%) 
27 (30.7%) 
p=0.470 
Body mass index 
<25 
25-30 
>30 
37 (21.6%) 
83 (48.5%) 
51 (29.8%) 
12 (13.8%) 
43 (49.4%) 
32 (36.8%) 
p=0.253 
Diabetes 
yes 
no 
24 (13.8%) 
149 (86.1%) 
16 (18.2%) 
72 (81.8%) 
p=0.361 
Hypertension 
yes 
no 
109 (63.0%) 
64 (37.0%) 
69 (78.4%) 
19 (21.6%) 
p=0.012* 
Dyslipidemia yes 80 (46.2%) 61 (69.3%) p<0.001* 
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no 93 (53.8%) 27 (30.7%) 
Smoking 
yes 
no 
20 (11.6%) 
153 (88.4%) 
12 (13.6%) 
76 (86.4%) 
p=0.629 
Family history of CAD+ 
yes 
no 
19 (11.0%) 
154 (89.0%) 
12 (13.6%) 
76 (86.4%) 
p=0.531 
Coronary artery 
calcium score 
>100 
<100 
15 (8.7%) 
158 (91.3%) 
64 (72.7%) 
24 (27.3%) 
p<0.001* 
Morise score 
<8 
8-16 
≥ 16 
28 (16.2%) 
96 (55.5%) 
49 (28.3%) 
5 (5.7%) 
42 (47.7%) 
41 (46.6%) 
p=0.003* 
Diamond Forrester 
model 
 
None 
Low (<30%) 
Intermediate (30-70%) 
High (≥70%) 
34 (19.7%) 
8 (4.6%) 
92 (53.2%) 
39 (22.5%) 
15 (17%) 
1 (1.1%) 
35 (39.8%) 
37 (42.0%) 
p=0.007* 
 
+coronary artery disease 
*statistically significant p<0.05 
 
Table 3 Multivariate predictors of high coronary atherosclerotic burden (CT-LeScT3) 
 
Variables Odds ratio (95% CI) p-value 
Age  1.031 (0.992-1.072) 0.118 
Male sex 3.501 (1.497-8.188) 0.004* 
Body mass index 0.944 (0.859-1.037) 0.231 
Diabetes 0.599 (0.208-1.729) 0.344 
Hypertension 1.145 (0.506-2.593) 0.745 
Dyslipidemia 3.380 (1.563-7.306) 0.002* 
Smoking 1.351 (0.472-3.869) 0.575 
Family history of CAD+ 1.430 (0.502-4.073) 0.503 
CACS** 1.010 (1.007-1.014) <0.001* 
 
+coronary artery disease 
**coronary artery calcium score 
*statistically significant p<0.05, Cox & Snell R2=0.401 
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Figure 1 Patient selection and study design. cCTA – coronary computed tomography angiography; CABG – 
coronary artery bypass graft; PCI – percutaneous coronary intervention; N – number of patients; *consecutive 
sample of patients (January to June, 2008) 
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Figure 2 Risk categories according to Morise and Diamond Forrester pre-test probabilities for CAD+  
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Figure 3 Coronary artery calcium score categories in relation to CAD+ subgroups 
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